03 Feb 2009

Neglected Disease Research and Development: How Much Are We Really Spending?

There is little consensus on what constitutes a neglected disease or what new products are required. Specific R&D investment data are available for some neglected diseases but these cannot readily be compared since each survey uses different methodologies and covers different diseases, products, donors, and countries. For most neglected diseases, there is simply no information.

In order to address these information deficits, the Bill & Melinda Gates Foundation commissioned the George Institute for International Health to conduct five sequential annual surveys of global investment into R&D of new pharmaceutical products to prevent, manage, or cure diseases of the developing world. This article summarises key data from the first G-FINDER report.

Visit the Policy Cures website to learn more about the G-Finder reports.